Trilliome
Trilliome is developing a proprietary AI and human gut model platform capable of identifying molecular combinations that reprogram the microbiome — boosting keystone bacterial species and restoring functions linked to brain and immune health.
Zurich, Switzerlandwww.trilliome.com ↗
Total raised
€50k
€50,000
Funding rounds
1
Investors
1
distinct backers
Active since
2025-10
latest 2025-10
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood33
base rate 30% for Other
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-28 | Other | €50k | EIT Food Accelerator Network’s “Food as Medicine” programme | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy